MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research
By A Mystery Man Writer
Description
MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).
The novel STAT3 inhibitor WZ-2-033 causes regression of human
Molecules, Free Full-Text
LY294002, a PI3K Inhibitor, is an Autophagy and Apoptosis Inducer
Zingerone, an Orally Active Nontoxic Methoxyphenol, Possesses Anti-Inflammatory and Anti-Tumor Properties
Triple negative breast cancer: approved treatment options and
CBL0137 is an Histone Chaperone FACT Inhibitor
IMD-0354 is a Selective IKKβ Inhibitor
The novel STAT3 inhibitor WZ-2-033 causes regression of human
KGP94 is a Selective Inhibitor of Cathepsin L for Cancer Research
CX-5461 is an Orally Active rRNA Synthesis Inhibitor
Rociletinib (CO-1686) is an Orally Active EGFR-Mutant Inhibitor
from
per adult (price varies by group size)